Home
Conditions
Carcinoma, Bronchogenic

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,277 public trials 1,202 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Not yet recruiting

Effects of Infusion Timing on Treatment Response in Solid Tumors

NCT07630168

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +20 more
Locations: University of North Carolina at Chapel Hill, Department of Radiation Oncology Chapel Hill, North Carolina, United States

View Trial Details

Not yet recruiting

Navigation Bronchoscopy Guided Microwave Ablation Versus SBRT in Early NSCLC

NCT07722182

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Prince of Wales Hospital Hong Kong

View Trial Details

Not yet recruiting

Cemiplimab for Clinical Stage I, 2-3.9cm, Non-Small Cell Lung Cancer

NCT07720167

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Medical University of South Carolina Hollings Cancer Center Charleston, South Carolina, United States

View Trial Details

Not yet recruiting

Allogeneic NK Cell Therapy Combined With Standard Maintenance Treatment in Advanced Solid Tumors

NCT07551778

Conditions: Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +19 more
Locations: Not specified

View Trial Details

Not yet recruiting

Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 Levels

NCT07360743

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Institut Bergonie Bordeaux Bordeaux, France

APHP-Hôpital Ambroise Paré Boulogne-Billancourt, France

Centre Antoine Lacassagne Nice, France

Institut Gustave Roussy Villejuif, France

View Trial Details

Not yet recruiting

Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural Effusion

NCT07482605

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +18 more
Locations: Not specified

View Trial Details

Not yet recruiting

BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

NCT07625644

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +19 more
Locations: Not specified

View Trial Details

Not yet recruiting

Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC

NCT07671092

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +21 more
Locations: Research Facility Christchurch, New Zealand

View Trial Details

Not yet recruiting

In Vivo Fluorescence Molecular Bronchoscopy of Durvalumab-680LT in Patients With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) After Chemoradiotherapy

NCT07653438

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1

NCT07450183

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Henry Ford Health Detroit, Michigan, United States

View Trial Details

Carcinoma, Bronchogenic

Carcinoma, Bronchogenic trial results

Related conditions